Sangamo Therapeutics, Inc.
METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS
Last updated:
Abstract:
The present disclosure is in the field of diagnostics and therapeutics for Alzheimer's Disease.
Status:
Application
Type:
Utility
Filling date:
2 Oct 2019
Issue date:
2 Apr 2020